See also this year's filing and all EDGAR filings for this company.
PDF Report 0001401914_2024_Dare_Bioscience_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 2807885, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001401914, Dare Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 17,543,539 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 655,975 |
| 3 | remainder_Assets | 3,082,701 |
| 4 | LiabilitiesCurrent | 20,480,436 |
| 5 | LiabilitiesNoncurrent | 1,935,743 |
| 6 | remainder_Liabilities | 3,913,676 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,302,230 |
| 9 | ResearchAndDevelopmentExpense | 11,722,132 |
| 10 | remainder_Expenses | 100,000 |
| 11 | remainder_Revenues | 6,932,815 |
| 12 | remainder_NetIncome | 747,883 |
| 13 | remainder_ComprehensiveNetIncome | -109,566 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 21,282,215 |
| 1 | Liabilities | 26,329,855 |
| 2 | Expenses | 24,124,362 |
| 3 | Revenues | 6,932,815 |
| 4 | StockholdersEquity | -5,047,640 |
| 5 | NetIncome | -16,443,664 |
| 6 | ComprehensiveNetIncome | -16,498,447 |
| 7 | BaseVar | 39,763,348 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.16 |
| 9 | EconomicCapitalRatio | 1.27 |
Edgar->Model Mapping
Feature Distribution
Change over Time
